OIL
Price sensitive
Halfway Mark Reached in Optiscan Breast Cancer Study
Optiscan Imaging Ltd
No summary is available for this announcement — open the PDF to read it in full.
Sign in for more about this company, including guidance changes and other insights.
Sign in